Skip to main content

Advertisement

SpringerLink
Log in

Concurrent Chemoradiotherapy or Endoscopic Stenting for Advanced Squamous Cell Carcinoma of Esophagus: A Case-Control Study

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

We evaluated the role of chemoradiotherapy (CRT) for patients with inoperable squamous esophageal cancer.

Methods

Patients with locally advanced or metastatic squamous esophageal carcinoma who received CRT were recruited. The CRT consists of continuous infusion of 5-fluorouracil at 200 mg/m2/day, and cisplatin at 60 mg/m2 on days 1 and 22, with concurrent radiotherapy for a total of 50 to 60 Gy in 25 to 30 fractions over 6 weeks. Efficacy was assessed by endoscopy and computed tomographic scan before and 8 weeks after completion of the treatment program. Median survival and the need for palliative esophageal stenting were compared with another group of patients who received endoscopic stenting.

Results

From 1996 to 2003, a total of 36 consecutive patients (33 male, mean ± SD age 63.2 ± 9.5 years) with T4 disease (81%) with or without cervical nodal metastasis (50%) received CRT, while 36 patients treated with endoscopic stenting alone were recruited as controls. Both groups were comparable in demographics, pretreatment dysphagia score, comorbidities, and tumor characteristics. CRT was completed in 32 patients (89%). There was no treatment-related mortality. Tumor volume was greatly reduced after CRT in 19 patients. Four patients (11%) received salvage esophagectomy 9 to 42 months after CRT. Compared with the stenting group, CRT statistically significantly improved 5-year survival (15% vs. 0%, P = .01), median survival (10.8 months vs. 4.0 months, P < .005), and need for stenting (22% vs. 100%, P = .005).

Conclusions

Palliative CRT can effectively improve the symptoms of dysphagia in patients with inoperable squamous esophageal carcinoma. It results in better survival compared with endoscopic stenting in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG. 3.

Similar content being viewed by others

References

  1. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: a critical review of surgery. Br J Surg 1980;67:381–90

    Article  PubMed  CAS  Google Scholar 

  2. Muller JM, Erasmi H, Stelzner M, et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845–57

    Article  PubMed  CAS  Google Scholar 

  3. Gurtner GC, Robertson CS, Chung SC, et al. Two-team synchronous oesophagectomy. Br J Surg 1994;81:1620–2

    Article  PubMed  CAS  Google Scholar 

  4. Katlic MR, Wilkins EW, Grillo HC. Three decade of treatment of esophageal squamous carinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 1990;99:929–38

    PubMed  CAS  Google Scholar 

  5. Chiu PW, Chan AC, Leung SF, et al. Multi-center prospective randomized trial comparing standard esophagectomy against chemo-radiotherapy for treatment of squamous esophageal cancer—early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005;9:794–802

    Article  PubMed  Google Scholar 

  6. Richmond J, seydel HG, Bae Y, et al. Comparison of three treatment strategies for esophageal cancer within a single institution. Int J Radiat Oncol Biol Phys 1987;13:1617–20

    PubMed  CAS  Google Scholar 

  7. John MJ, Flam MS, Mowry PA, et al. Radiation alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989;63:2397–403

    Article  PubMed  CAS  Google Scholar 

  8. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: highdose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167–74

    Article  PubMed  CAS  Google Scholar 

  9. Coia LR, Minsky BD, Berkey BA, et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992–1994 Patterns of Care Study. J Clin Oncol 2000;18:455–62

    PubMed  CAS  Google Scholar 

  10. Minsky BD. Carcinoma of the esophagus. Part 1: primary therapy. Oncology 1999;13:1225–36

    PubMed  CAS  Google Scholar 

  11. Harney J, Goodchild K, Philip H, et al. A phase III study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of oesophagus. Clin Oncol 2003;15:109–14

    Article  CAS  Google Scholar 

  12. Seitz JF, Milan C, Giovannini M, et al. [Concurrent concentrated radio-chemotherapy of epidermal cancer of the esophagus. Long-term results of a phase II national multicentre trial in 122 non-operable patients (FFCD 8803)]. Gastroenterol Chin Biol 2000;24:201–10

    CAS  Google Scholar 

  13. Griffith JF, Chan AC, Chow LT, et al. Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT. Br J Radiol 1999;72:678–84

    PubMed  CAS  Google Scholar 

  14. Griffith JF, Chan AC, Ahuja AT, et al. Neck ultrasound in staging squamous oesophageal carcinoma—a high yield technique. Clin Radiol 2000;55:696–701

    Article  PubMed  CAS  Google Scholar 

  15. Herskovoc A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593–8

    Article  Google Scholar 

  16. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up a prospective randomized trial (RTOG 85-01). JAMA 1999;281:1623–7

    Article  PubMed  CAS  Google Scholar 

  17. Yano M, Inoue M, Shiozaki H. Preoperative concurrent chemotherapy asnd radiotherapy followed by surgery for esophageal cancer. Ann Thorac Cardiovasc Surg 2002;8:123–30

    PubMed  Google Scholar 

  18. Franklin R, Steiger Z, Vaiahampayan G, et al. Combined modality therapy for esophageal squamous cell carcinoma. Cancer 1983;51:1062–71

    Article  PubMed  CAS  Google Scholar 

  19. Urschel J D, Ashiku S, Thurer R, et al. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer—a review. Dis Esophagus 2003;16:60–5

    Article  PubMed  CAS  Google Scholar 

  20. Wilson KS, Lim JT. Primary chemo-radiotherapy and selective esophagectomy for esophageal cancer: goal of cure with organ preservation. Radiother Oncol 2000;54:129–34

    Article  PubMed  CAS  Google Scholar 

  21. Murakami M, Kuroda Y, Okamoto Y, et al. Neoadjuvant concurrent chemoradiotherapy followed by definitive high dose radiotherapy or surgery for operable thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 1998;40:1049–59

    PubMed  CAS  Google Scholar 

  22. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell carcinoma of esophagus. N Engl J Med 1997;337:161–7

    Article  PubMed  CAS  Google Scholar 

  23. Noguchi T, Moriyama H, Wada S, et al. Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esophagus 2003;16:94–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

    Simon K. H. Wong MBChB, FRCSEd, Philip W. Y. Chiu MBChB, FRCSEd, K. Y. Cheung MBChB, FRSCEd, Angus C. W. Chan MD, FRCS, Alex C. M. Au-Yeung BSc, Sydney S. C. Chung MD, FRCP, FRCS & Enders K. W. Ng MD, FRCSEd

  2. Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

    S. F. Leung MD, FRCR

  3. Department of Radiology and Organ Imaging, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

    James F. Griffith FRCR

Authors
  1. Simon K. H. Wong MBChB, FRCSEd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip W. Y. Chiu MBChB, FRCSEd
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. F. Leung MD, FRCR
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Y. Cheung MBChB, FRSCEd
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Angus C. W. Chan MD, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alex C. M. Au-Yeung BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. James F. Griffith FRCR
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sydney S. C. Chung MD, FRCP, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Enders K. W. Ng MD, FRCSEd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Enders K. W. Ng MD, FRCSEd.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, S.K.H., Chiu, P.W.Y., Leung, S.F. et al. Concurrent Chemoradiotherapy or Endoscopic Stenting for Advanced Squamous Cell Carcinoma of Esophagus: A Case-Control Study. Ann Surg Oncol 15, 576–582 (2008). https://doi.org/10.1245/s10434-007-9679-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9679-y

Keywords

Search

Navigation